Growing community of inventors

Dublin, Ireland

William Finlay

Average Co-Inventor Count = 12.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 21

William FinlayJun Zhang (3 patents)William FinlayHaichun Huang (3 patents)William FinlayBrigitte Devaux (3 patents)William FinlayPeter Brams (3 patents)William FinlayKarla Ann Henning (3 patents)William FinlayTetsuya Ishino (3 patents)William FinlayRobert Arch (3 patents)William FinlayJoel Bard (3 patents)William FinlayOrla Cunningham (3 patents)William FinlayCiara Reilly (3 patents)William FinlayMichelle M Mader (1 patent)William FinlayMichelle Madar (1 patent)William FinlayMichelle Mader (1 patent)William FinlayJun Zhang (1 patent)William FinlayCiara Reilly (1 patent)William FinlayWilliam Finlay (3 patents)Jun ZhangJun Zhang (98 patents)Haichun HuangHaichun Huang (80 patents)Brigitte DevauxBrigitte Devaux (32 patents)Peter BramsPeter Brams (28 patents)Karla Ann HenningKarla Ann Henning (22 patents)Tetsuya IshinoTetsuya Ishino (7 patents)Robert ArchRobert Arch (4 patents)Joel BardJoel Bard (4 patents)Orla CunninghamOrla Cunningham (3 patents)Ciara ReillyCiara Reilly (3 patents)Michelle M MaderMichelle M Mader (3 patents)Michelle MadarMichelle Madar (1 patent)Michelle MaderMichelle Mader (1 patent)Jun ZhangJun Zhang (26 patents)Ciara ReillyCiara Reilly (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (3 from 4,455 patents)

2. Bristol-myers Squibb Compnay (3 from 3,684 patents)


3 patents:

1. 12372536 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

2. 11474112 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

3. 9683998 - Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…